BCR and systemic lupus erythematosus: On the other hand, another member of beta2-integrins, CD11b/CD18, has been reported to inhibit BCR signaling to maintain autoreactive B cell tolerance [39], and CD11b is one of the strongest genetic risk factors for SLE [40, 41].